{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:01:16Z","timestamp":1791500476433,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.nmd.2007.11.002","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T15:57:35Z","timestamp":1201190255000},"page":"227-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment"],"prefix":"10.1016","volume":"18","author":[{"given":"Hannah G.","family":"Radley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda D.","family":"Grounds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2007.11.002_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1542\/pir.27.3.83","article-title":"Duchenne muscular dystrophy","volume":"27","author":"Biggar","year":"2006","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.nmd.2007.11.002_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"The Lancet"},{"key":"10.1016\/j.nmd.2007.11.002_bib3","doi-asserted-by":"crossref","unstructured":"Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sacolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993; 90.","DOI":"10.1073\/pnas.90.8.3710"},{"key":"10.1016\/j.nmd.2007.11.002_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.nmd.2005.03.007","article-title":"Postnatal changes in sarcolemmal organization in the mdx mouse","volume":"15","author":"Reed","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2007.11.002_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.nmd.2007.11.002_bib6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0960-8966(01)00198-5","article-title":"Do immune cells promote the pathology of dystrophin-deficient myopathies?","volume":"11","author":"Spencer","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2007.11.002_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1096\/fj.03-1024com","article-title":"Anti-TNF\u03b1 (Remicade) therapy protects dystrophic skeletal muscle from necrosis","volume":"18","author":"Grounds","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.nmd.2007.11.002_bib8","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00454.2004","article-title":"Inflammatory processes in muscle injury and repair","volume":"288","author":"Tidball","year":"2005","journal-title":"Am J Physiol \u2013 Regul Integr Comp Physiol"},{"key":"10.1016\/j.nmd.2007.11.002_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nmd.2006.06.011","article-title":"Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNF-alpha function with Etanercept in mdx mice","volume":"16","author":"Hodgetts","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2007.11.002_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.06-7285com","article-title":"Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression","volume":"21","author":"Pescatori","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.nmd.2007.11.002_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/clim.2000.4966","article-title":"Helper (CD4+) and cytotoxic (CD8+) T cells promote the pathology of dystrophin-deficient muscle","volume":"98","author":"Spencer","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nmd.2007.11.002_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s000110300068","article-title":"Administration of the non-steroidal anti-inflammatory drug ibuprofen increases macrophage concentrations but reduces necrosis during modified muscle use","volume":"52","author":"Cheung","year":"2003","journal-title":"Inflamm Res"},{"key":"10.1016\/j.nmd.2007.11.002_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1083\/jcb.200105110","article-title":"A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice","volume":"155","author":"Wehling","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2007.11.002_bib14","first-page":"287","article-title":"Cromolyn increases strength in exercised mdx mice","volume":"91","author":"Granchelli","year":"1996","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1016\/j.nmd.2007.11.002_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.nbd.2006.03.016","article-title":"Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice","volume":"23","author":"Radley","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nmd.2007.11.002_bib16","first-page":"16","article-title":"The mode of action of cytokine inhibitors","volume":"65","author":"Arend","year":"2002","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.nmd.2007.11.002_bib17","doi-asserted-by":"crossref","first-page":"C370","DOI":"10.1152\/ajpcell.00453.2002","article-title":"TNF-a is a mitogen in skeletal muscle","volume":"285","author":"Li","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.nmd.2007.11.002_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cytogfr.2007.04.002","article-title":"How TNF was recognized as a key mechanism of disease","volume":"18","author":"Clark","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.nmd.2007.11.002_bib19","unstructured":"Grounds MD, Radley HG, Gebski BL, Bogoyevitch MA, Shavlakadze T. Implications of cross-talk between TNF and IGF-1 signalling in skeletal muscle. Clin Exp Pharmacol Physiol, in press."},{"key":"10.1016\/j.nmd.2007.11.002_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.expneurol.2005.11.021","article-title":"Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice","volume":"198","author":"Messina","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2007.11.002_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00401-002-0635-4","article-title":"Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies","volume":"105","author":"Kuru","year":"2003","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.nmd.2007.11.002_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00441-005-1102-z","article-title":"Silencing TNF\u03b1 activity using Remicade\u00ae or Enbrel\u00ae blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice","volume":"320","author":"Grounds","year":"2005","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.nmd.2007.11.002_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1191\/096032700678815765","article-title":"Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFalpha monoclonal antibody","volume":"19","author":"Treacy","year":"2000","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.nmd.2007.11.002_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10067-006-0312-4","article-title":"Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis","volume":"26","author":"Kageyama","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.nmd.2007.11.002_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/00006676-200401000-00020","article-title":"Infliximab: a new therapeutic agent in acute pancreatitis?","volume":"28","author":"Oruc","year":"2004","journal-title":"Pancreas"},{"key":"10.1016\/j.nmd.2007.11.002_bib26","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.4049\/jimmunol.171.10.5514","article-title":"A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease","volume":"171","author":"Woodruff","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.nmd.2007.11.002_bib27","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/01.BRS.0000083162.35476.FF","article-title":"Changes in spontaneous behavior in rats exposed to experimental disc herniation are blocked by selective TNF-alpha inhibition","volume":"28","author":"Olmarker","year":"2003","journal-title":"Spine"},{"key":"10.1016\/j.nmd.2007.11.002_bib28","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.145.11.3762","article-title":"Requirement of endogenous tumor necrosis factor\/cachectin for recovery from experimental peritonitis","volume":"145","author":"Echtenacher","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.nmd.2007.11.002_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2004.01.006","article-title":"Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency","volume":"41","author":"Scallon","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nmd.2007.11.002_bib30","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","article-title":"X chromosome-linked muscular dystrophy (mdx) in the mouse","volume":"81","author":"Bulfield","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2007.11.002_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2990.1988.tb00866.x","article-title":"The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation","volume":"14","author":"Coulton","year":"1988","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nmd.2007.11.002_bib32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ymthe.2004.07.026","article-title":"Targeted expression of insulin-like growth factor-1 reduces the necrosis of dystrophic mdx muscle","volume":"10","author":"Shavlakadze","year":"2004","journal-title":"Mol Therapy"},{"key":"10.1016\/j.nmd.2007.11.002_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2006.03.003","article-title":"Differential calcineurin signalling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mdx mice","volume":"16","author":"Stupka","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2007.11.002_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0022-510X(93)90130-Q","article-title":"Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies","volume":"119","author":"McGeachie","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2007.11.002_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/1044-7431(92)90029-2","article-title":"Quantitation of muscle precursor cell activity in skeletal muscle by northern analysis of MyoD and myogenin expression \u2013 Application to dystrophic (mdx) mouse muscle","volume":"3","author":"Beilharz","year":"1992","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nmd.2007.11.002_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0960-8966(97)00115-6","article-title":"Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice","volume":"7","author":"Brussee","year":"1997","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2007.11.002_bib37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-4598(199805)21:5<567::AID-MUS2>3.0.CO;2-6","article-title":"Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise","volume":"21","author":"Vilquin","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2007.11.002_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0960-8966(99)00126-1","article-title":"Pre-clinical screening of drugs using the mdx mouse","volume":"10","author":"Granchelli","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2007.11.002_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0002-9440(10)62270-5","article-title":"A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice","volume":"166","author":"De Luca","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2007.11.002_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.20436","article-title":"Nutritional therapy improves function and complements corticosteroid intervention in mdx mice","volume":"33","author":"Payne","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2007.11.002_bib41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1096\/fj.05-4821fje","article-title":"Persistent and improved functional gain in mdx dystrophic mice after treatment with l-arginine and deflazacort","volume":"20","author":"Archer","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.nmd.2007.11.002_bib42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1258\/0023677041958927","article-title":"The use of sodium lamps to brightly illuminate mouse houses during their dark phases","volume":"38","author":"McLennan","year":"2004","journal-title":"Lab Anim (Lond)"},{"key":"10.1016\/j.nmd.2007.11.002_bib43","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1152\/jappl.2001.90.5.1900","article-title":"Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse","volume":"90","author":"Allen","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.nmd.2007.11.002_bib44","doi-asserted-by":"crossref","first-page":"R1321","DOI":"10.1152\/ajpregu.2000.279.4.R1321","article-title":"Treadmill running produces both positive and negative physiological adaptations in Sprague\u2013Dawley rats","volume":"279","author":"Moraska","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.nmd.2007.11.002_bib45","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1152\/jappl.1999.86.5.1696","article-title":"Differential expression of stress proteins in rat myocardium after free wheel or treadmill run training","volume":"86","author":"Noble","year":"1999","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.nmd.2007.11.002_bib46","first-page":"5","article-title":"The influence of revascularisation, vasoactive drugs and exercise on the regeneration of skeletal muscle, with particular reference to muscle transplantation","volume":"2","author":"Roberts","year":"1992","journal-title":"BAM"},{"key":"10.1016\/j.nmd.2007.11.002_bib47","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/002215540004801110","article-title":"Myotube formation is delayed but not prevented in MyoD-deficient skeletal muscle: studies in regenerating whole muscle grafts of adult mice","volume":"48","author":"White","year":"2000","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.nmd.2007.11.002_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0344-0338(11)81039-3","article-title":"Towards understanding muscle regeneration","volume":"187","author":"Grounds","year":"1991","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.nmd.2007.11.002_bib49","series-title":"Composite tissue transplantation","first-page":"121","article-title":"Therapeutic uses of muscle and factors controlling the efficiency of whole muscle graft regeneration","author":"Grounds","year":"1998"},{"key":"10.1016\/j.nmd.2007.11.002_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/excr.1993.1199","article-title":"The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis","volume":"207","author":"Robertson","year":"1993","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.nmd.2007.11.002_bib51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1469-7580.1999.19420287.x","article-title":"The timing between myoblast replication and fusion into myotubes, and the stability of regenerated myofibres in dystrophic muscle: an autoradiographic study in mdx mice","volume":"194","author":"McGeachie","year":"1999","journal-title":"J Anat"},{"key":"10.1016\/j.nmd.2007.11.002_bib52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/BJ20070149","article-title":"Targeting TNF-alpha with a tetravalent miniantibody TNF-TeAb","volume":"406","author":"Liu","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.nmd.2007.11.002_bib53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.0608277104","article-title":"Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy","volume":"104","author":"Brunelli","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2007.11.002_bib54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00418-004-0707-8","article-title":"Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice","volume":"122","author":"Salimena","year":"2004","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.nmd.2007.11.002_bib55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/mus.20820","article-title":"Effects of a CRF2R agonist and exercise on mdx and wildtype skeletal muscle","volume":"36","author":"Hall","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2007.11.002_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.freeradbiomed.2007.04.003","article-title":"Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice","volume":"43","author":"Kaczor","year":"2007","journal-title":"Free Radic Biol Med"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896607007572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896607007572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:56:05Z","timestamp":1760774165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896607007572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0960896607007572"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2007.11.002","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2007.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}